Search

everythinglearnresearchcommunity

for

Search:↓

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Dissolving microneedles show promise for treating hair loss but need more research for practical use.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The 810-nm diode laser improves skin texture in keratosis pilaris but not redness.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Natural products might help treat hair greying.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

MSC-derived EVs show promise for therapy, but production and understanding need improvement.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

MicroRNAs could help assess and manage multiple chronic diseases.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.